TechNavio today launched its report Global Bio-implants Market 2012-2016 based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”The increasing preference for minimally invasive surgery is one of the emerging trends in the Global Bio-implants market. There is an increasing demand for minimally invasive surgical procedures among the aging population across the world, and this is expected to spark the growth of the Global Bio-implants market. This is because minimally invasive surgery causes less pain, reduces the duration of the recovery process, causes minimal injuries, has low risk of infection, and minimizes bleeding. In addition, the cost efficiency offered by less invasive is expected to increase the demand for these procedures and for bio-implants in the near future. This trend will have a positive impact on the growth of the market.”
According to the report, the increasing prevalence of chronic diseases is one of the major drivers in the Global Bio-implants market. Globally, there has been an increase in the incidence of chronic diseases including cardiovascular disease, osteoarthritis, congenital disorders, and neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and trauma. This is due to a variety of factors such as unhealthy dietary habits, lack of physical activity, excessive consumption of alcohol, and excessive smoking. Thus, the increasing prevalence of these chronic diseases leads to the rise in demand for various bio-implants, such as cardiovascular implants, spinal implants, knee implants, hip implants, and neurostimulator implants to treat a variety of diseases. Hence, the increasing prevalence of chronic diseases will result in the growth of the Global Bio-implants market.
Further, the report states that the expensive nature of the procedures is one of the major challenges in the Global Bio-implants
Market.
The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Boston Scientific Corp., Medtronic Inc., Stryker Corp., and Synthes Inc. The other vendors mentioned in the report are St. Jude Medical Inc., DePuy Inc., Smith and Nephew plc, Tornier Inc., Zimmer Holdings Inc., Biomet Inc., aap Implantate AG, Biotronik SE and Co. KG, Acumed LLC, C. R. Bard Inc., Bausch and Lomb Inc., ArthroCare Corp., LDR Holdings Corp., Ceraver Osteal America Inc., Nobel Biocare Holding AG, MiMedx Group Inc., Corin Group plc, DJO Global Inc., Elite Surgical Supplies (Pty) Ltd., Endotec Inc., Exactech Inc., Wright Medical Group Inc., Osteomed L.P., Merete Medical GmbH, Vilex In Tennessee Inc., Waldemar Link GmbH and Co. KG, and Memometal Technologies S.A.S.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-bio-implants-market-2012-2016
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Global Bio-implants Market 2012-2016
